LFG
ZVRA icon

Larson Financial Group’s Zevra Therapeutics ZVRA Stock Holding History

Larson Financial Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.78K Hold
473
– – ﹤0.01% 2628
2026
Q1 		$4.41K Hold
473
– – ﹤0.01% 2663
2025
Q4 		$4.24K Buy
473
+65
+16% +$615 ﹤0.01% 2523
2025
Q3 		$3.88K Buy
408
+15
+4% +$150 ﹤0.01% 2443
2025
Q2 		$3.46K Buy
393
+283
+257% +$2.3K ﹤0.01% 2224
2025
Q1 		$824 Hold
110
– – ﹤0.01% 2437
2024
Q4 		$917 Sell
110
-1
-0.9% -$9 ﹤0.01% 2061
2024
Q3 		$770 Hold
111
– – ﹤0.01% 2040
2024
Q2 		$544 Hold
111
– – ﹤0.01% 1821
2024
Q1 		$644 Hold
111
– – ﹤0.01% 1521
2023
Q4 		$727 Buy
+111
New +$519 ﹤0.01% 1528

Other funds holding ZVRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Larson Financial Group's ZVRA Position: Q2 2026 in Review

Larson Financial Group held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 473 shares worth $6.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2628.

Larson Financial Group first reported a position in ZVRA in Q4 2023 and has held it in 11 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

  • Larson Financial Group held 473 shares of Zevra Therapeutics worth $6.78K as of Q2 2026.
  • Larson Financial Group left its Zevra Therapeutics share count unchanged in Q2 2026.
  • Zevra Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #2628 holding.
  • Larson Financial Group first reported a position in Zevra Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • 157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.